QUOTED. April 30, 2019. Bill Edelman.
Paragonix Technologies is getting ready to market the first US FDA and CE-marked medical device system for transporting donor hearts. See what Paragonix's CEO Bill Edelman said about the company's SherpaPak Cardiac Transport system here:
"[With using the traditional method], the organ is actually compressed between two layers of crushed ice and is sometimes flattened out, and other times the heart muscle itself comes into very direct contact with the ice itself and that can freeze the muscle, so that ice-crystals can form inside the tissue, and that could adversely affect how the muscle recovers after it's been implanted into the recipient." –Bill Edelman, CEO, Paragonix Technologies
Click here for a free trial of Medtech Insight